Related Experiment Videos

Rapid decline in FEV1. A new risk factor for coronary heart disease mortality

M S Tockman1, J D Pearson, J L Fleg

  • 1Department of Environmental Health Sciences, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Maryland 21205.

Insights

A rapid decline in forced expiratory volume in one second (FEV1) predicts coronary heart disease (CHD) mortality in men, independent of other risk factors. This finding highlights lung function decline as a crucial indicator for cardiovascular health.

Area of Science:

  • Cardiology
  • Pulmonology
  • Epidemiology

Background:

  • Coronary heart disease (CHD) is a primary cause of death in the U.S.
  • Pulmonary function, specifically forced expiratory volume in one second (FEV1), has been investigated for its association with cardiovascular health.

Purpose of the Study:

  • To investigate if the rate of FEV1 decline independently predicts CHD mortality in apparently healthy men.
  • To assess the relationship between FEV1 decline and all-cause mortality.

Main Methods:

  • A cohort study of 883 White male participants from the Baltimore Longitudinal Study of Aging (BLSA) without pre-existing CHD.
  • Data collected included pulmonary function tests, lipid profiles, smoking status, blood pressure, and body mass index.
  • A time-dependent proportional hazards model was used to analyze CHD mortality over an average follow-up of 17.4 years.

Main Results:

  • An increased rate of FEV1 decline was associated with significantly higher cardiac mortality (relative risk [RR] 2.92-5.13).
  • This association remained significant even after adjusting for age, initial FEV1, smoking, hypertension, and cholesterol levels.
  • No significant association was found between FEV1 decline and all-cause mortality.

Conclusions:

  • Accelerated FEV1 decline is an independent predictor of CHD mortality in men.
  • Lung function decline may serve as an early warning sign for cardiovascular risk.
  • These findings emphasize the importance of considering pulmonary health in cardiovascular risk assessment.

Related Concept Videos